期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

天疱疮疗效评估的研究进展 被引量：5

原文传递
导出
摘要 基于医疗相关成本控制的需要及循证医学的发展，临床疗效评估的概念于20世纪80年代被提出并飞速进展，认为对于判断疾病轻重变化、评估治疗效果等临床实践及临床科研至关重要。在皮肤科领域，皮肤作为人体可以直视的最大器官，很大程度依赖于临床评估病情及疗效，而不是首要依赖于各种实验室或特殊检查手段。
作者 张洁尘 冯素英 王宝玺
机构地区 中国医学科学院北京协和医学院皮肤病研究所
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2012年第1期60-62,共3页 Chinese Journal of Dermatology
基金 卫生部公益性行业科研专项经费项目（201002016）
关键词 疗效评估 天疱疮 临床科研 循证医学 成本控制 临床实践 治疗效果 临床评估
分类号 R758.6 [医药卫生—皮肤病学与性病学]
  • 相关文献

参考文献15

  • 1Singer AJ,Thode HC Jr,Hollander JE.Research fundamentals:selection and development of clinical outcome measures.Acad Emerg Med,2000,7(4):397-401.
  • 2Feldman SR,Krueger GG.Psoriasis assessment tools in clinical trials.Ann Rheum Dis,2005,64 Suppl 2:ii65-ii68; discussion ii69-ii73.
  • 3Kunz B,Oranje AP,Labrèze L,et al.Clinical validation and guidelines for the SCORAD index:consensus report of the European Task Force on Atopic Dermatitis.Dermatology,1997,195(1):10-19.
  • 4Charman C,Williams H.Outcome measures of disease severity in atopic eczema.Arch Dermatol,2000,136(6):763-769.
  • 5Bombardier C,Gladman DD,Urowitz MB,et al.Derivation of the SLEDAI.A disease activity index for lupus patients.The Committee on Prognosis Studies in SLE.Arthritis Rheum,1992,35(6):630-640.
  • 6Agarwal M,Walia R,Kochhar AM,et al.Pemphigus Area and Activity Score (PAAS)-a novel clinical scoring method for monitoring of pemphigus vulgaris patients.Int J Dermatol,1998,37(2):158-160.
  • 7Pfütze M,Niedermeier A,Hertl M,et al.Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus.Eur J Dermatol,2007,17(1):4-11.
  • 8Saraswat A,Bhushan K,India C.A new grading system for oral pemphigus.Int J Dermatol,2003,42(5):413-414.
  • 9Murrell DF,Dick S,Ahmed AR,et al.Consensus statement on definitions of disease,end points,and therapeutic response for pemphigus.J Am Acad Dermatol,2008,58(6):1043-1046.
  • 10Rosenbach M,Murrell DF,Bystryn JC,et al.Reliability and convergent validity of two outcome instruments for pemphigus.J Invest Dermatol,2009,129(10):2404-2410.

二级参考文献10

  • 1朱学骏,李冠群.60例天疱疮的皮在固醇激素治疗及预后观察[J].临床皮肤科杂志,1993,22(4):190-192. 被引量：13
  • 2冯素英,靳培英.静脉滴注免疫球蛋白治疗皮肤病的现状[J].中华皮肤科杂志,2005,38(6):396-398. 被引量：24
  • 3王娣,陈喜雪,朱学骏.124例大疱性类天疱疮治疗回顾[J].中华皮肤科杂志,2007,40(1):7-9. 被引量：31
  • 4Chams-Davatchi C, Valikhani M, Daneshpazhooh M, et al. Pemphigus: analysis of 1209 cases. Int J Dermatol, 2005, 44 (6): 470-476.
  • 5Inchara YK, Rajalakshmi T. Direct immunofluorescence in cutaneous vesiculobullous lesions. Indian J Pathol Microbiol, 2007, 50(4):730-732.
  • 6Zhu X J, Niimi Y, Bystryn JC. Epidermolysis bullosa acquisita. Incidence in patients with basement membrane zone antibodies. Arch Dermatol, 1990, 126(2): 171-174.
  • 7Sitaru C, Mihai S, Zillikens D. The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases. Arch Dermatol Res, 2007, 299( 1 ): 1-8.
  • 8Lever WF, Schaumburg-Lever G. Immunosuppressants and prednisone in pemphigus vulgaris: therapeutic results obtained in 63 patients between 1961 and 1975. Arch Dermatol, 1977, 113(9): 1236-1241.
  • 9Herbst A, Bystryn JC. Patterns of remission in pemphigus vulgaris. J Am Acad Dermatol, 2000, 42(3): 422-427.
  • 10范青源.大疱性类天疱疮的诊疗进展[J].国外医学（皮肤性病学分册）,1999,25(6):360-362. 被引量：5

共引文献62

同被引文献38

  • 1金岩,付海军,翁孟武.HLA-Ⅱ类基因与大疱性类天疱疮的相关性研究[J].中华皮肤科杂志,2003,36(7):368-371. 被引量：9
  • 2杨春俊,刘盛秀,高建国,李卉,杜文辉,王培光,杨森.红斑型天疱疮伴发格林-巴利综合征1例[J].中国皮肤性病学杂志,2005,19(6):368-369. 被引量：1
  • 3宋韬,刘慧荣.泛发型白癜风并发红斑型天疱疮1例[J].临床皮肤科杂志,2006,35(10):664-665. 被引量：1
  • 4Chameux J, Lorin J, Vitry F, et al. Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients[J]. Arch Dermatol, 2011,147(3 ): 286-291. DOI: 10.1001/ archdermatol.2011.23.
  • 5Feng S, Wu Q, Jin P, et al. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid [J]. Int J Dermatol, 2008, 47 (3): 225-228. DOI: 10.1111/j.1365- 4632.2008.03473.x.
  • 6Pfutze M, Niedermeier A, Hertl M, et al. Introducing a novel autoimmune bullous skin disorder intensity score (ABSIS) in pemphigus[J]. Eur J Dermatol, 2007,17 (1): 4-11. DOI: 10.1684/ ejd.2007.0090.
  • 7Daniel BS, Hertl M, Werth VP, et al. Severity score indexes for blistering diseases[J]. Clin Dermatol, 2012, 30( 1 ): 108-113. DOI: 10.1016/j.clindermatol.2011.03.017.
  • 8Rahbar Z, Daneshpazhooh M, Mirshams-Shahshahani M, et al. Pemphigus disease activity measurements: pemphigus disease area index, autoimmune bullous skin disorder intensity score, and pemphigus vulgaris activity score [J]. JAMA Dermatol, 2014, 150 (3): 266-272. DO/: 10.1001/iamadermatol.2013.8175.
  • 9Murrell DF, Daniel BS, Joly P, et al. Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts [J]. J Am Acad Dermatol, 2012, 66 ( 3 ): 479-485. DOI: 10.1016/j.jaad.2011.06.032.
  • 10Patsatsi A, Kyriakou A, Pavlitou-Tsiontsi A, et al. Association of autoantibodies to BP180 with disease activity in Greek patients with bullous pemphigoid [J]. Clin Dev Immunol, 2012, 2012: 854795. DOI: 10.1155/2012/854795.

引证文献5

二级引证文献21

中华皮肤科杂志
2012年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部